Altium Capital Management’s Inspire Medical Systems INSP Stock Holding History

Altium Capital Management’s Portfolio INSP Stock Details INSP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-12,500	Closed	-$2.93M	–	80
2023 Q1	$2.93M	Buy	+12,500	New	+$3.16M	1.62%	24
2022 Q4	–	Sell	-12,000	Closed	-$2.13M	–	114
2022 Q3	$2.13M	Sell	12,000 -12,000	-50%	-$2.41M	0.78%	52
2022 Q2	$4.38M	Buy	24,000 +8,000	+50%	+$1.6M	1.75%	13
2022 Q1	$4.11M	Sell	16,000 -7,000	-30%	-$1.6M	1.37%	29
2021 Q4	$5.29M	Sell	23,000 -3,000	-12%	-$732K	1.46%	20
2021 Q3	$6.05M	Buy	26,000 +5,345	+26%	+$1.12M	1.59%	15
2021 Q2	$3.99M	Buy	+20,655	New	+$4.1M	0.93%	38

Other funds holding INSP

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return

Altium Capital Management's INSP Position: Q2 2023 in Review

Altium Capital Management sold out of Inspire Medical Systems (INSP) in Q2 2023, closing a stake of 12,500 shares — an estimated $2.93M sold.

Altium Capital Management first reported a position in INSP in Q2 2021 and held it in 7 quarters. The position peaked at $6.05M in Q3 2021. 407 funds tracked by Wall St. Rank hold INSP as of Q2 2023.

Altium Capital Management reported no remaining Inspire Medical Systems position as of Q2 2023 after selling out during the quarter.
Altium Capital Management sold 12,500 Inspire Medical Systems shares in Q2 2023, an estimated $2.93M.
Altium Capital Management first reported a position in Inspire Medical Systems in Q2 2021 and held it in 7 quarters.
Altium Capital Management's Inspire Medical Systems position peaked at $6.05M in Q3 2021.
407 funds tracked by Wall St. Rank held Inspire Medical Systems as of Q2 2023.

Based on Altium Capital Management's 13F filing for Q2 2023, filed 14 Aug 2023.